Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001827506-25-000011
Filing Date
2025-01-29
Accepted
2025-01-29 16:23:21
Documents
1
Period of Report
2025-01-27

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1738185794.html 4  
1 FORM 4 wk-form4_1738185794.xml 4 3987
  Complete submission text file 0001827506-25-000011.txt   5575
Mailing Address 200 CONNELL DRIVE SUITE 1600 BERKELEY HEIGHTS NJ 07922
Business Address
MIDDLEKAUFF W BRADFORD (Reporting) CIK: 0001214501 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40384 | Film No.: 25569677

Mailing Address 27 WEST 24TH STREET SUITE 702 NEW YORK NY 10010
Business Address 27 WEST 24TH STREET SUITE 702 NEW YORK NY 10010 646-481-9832
Tourmaline Bio, Inc. (Issuer) CIK: 0001827506 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)